Essai thérapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulcère de buruli surinfecte
- Other title
- Nitrofurantoine associated with metronidazole: a clinical trial in the treatment of infected Buruli ulcer (en)
- Author
- KIBADI, K1 ; TSAKALA, T. M2 ; MPUTU YAMBA, J. B3 ; KASHONGWE, M3 ; MUYEMBE, T4 ; IMPOSO, I5
[1] Département de Chirurgie, Cliniques Universitaires de Kinshasa, B.P 834, Kinshasa XI, Zimbabwe
[2] Laboratoire de Pharmacie Galénique, Faculté de Pharmacie, Université de Kinshasa, B.P791, KinshasaXI, Zimbabwe
[3] Département de Médecine Interne, Cliniques Universitaires, B P 834, Kinshasa XI, Zimbabwe
[4] Laboratoire de Bactériologie, Cliniques Universitaires, B P 834, Kinshasa XI, Zimbabwe
[5] Service de Chirurgie, Hôpital Général de Référence IME-KiMPESE, Zimbabwe - Source
Médecine d'Afrique Noire. 2002, Vol 49, Num 5, pp 239-243 ; ref : 8 ref
- CODEN
- MAFNAS
- ISSN
- 0465-4668
- Scientific domain
- Tropical medicine
- Publisher
- [SOPEMI], Dakar
- Publication country
- Senegal
- Document type
- Article
- Language
- French
- Keyword (fr)
- Antibactérien Antiseptique Association médicamenteuse Chimiothérapie Composé nitro Efficacité traitement Furane dérivé Homme Imidazole dérivé Métronidazole Nitrofurantoïne Sulfonamide Tosylchloramide sodique Traitement Ulcère Buruli Voie locale Congo Brazzaville Bactériose Infection Mycobactériose Peau pathologie Afrique
- Keyword (en)
- Antibacterial agent Antiseptic Drug combination Chemotherapy Nitro compound Treatment efficiency Furan derivatives Human Imidazole derivatives Metronidazole Nitrofurantoin Sulfonamide Tosylchloramide sodium Treatment Buruli ulcer Local administration Congo Bacteriosis Infection Mycobacterial infection Skin disease Africa
- Keyword (es)
- Antibacteriano Antiséptico Asociación medicamentosa Quimioterapia Compuesto nitro Eficacia tratamiento Furano derivado Hombre Imidazol derivado Metronidazol Nitrofurantoína Sulfonamida Tosilcloramida sódica Tratamiento Ulcera Buruli Vía local Congo Brazzaville Bacteriosis Infección Micobacteriosis Piel patología Africa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S02 Antibacterial agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S06 Antiparasitic agents
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13730027
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:9:\"\u0000*\u0000jtitle\";s:25:\"M\u00e9decine d'Afrique Noire\";s:9:\"\u0000*\u0000stitle\";s:16:\"M\u00e9d. Afr. Noire\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"239\";s:8:\"\u0000*\u0000epage\";s:3:\"243\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0465-4668\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KIBADI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:13:\"TSAKALA, T. M\";i:1;s:17:\"MPUTU YAMBA, J. B\";i:2;s:12:\"KASHONGWE, M\";i:3;s:10:\"MUYEMBE, T\";i:4;s:9:\"IMPOSO, I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MAFNAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:8:\"\u0000*\u0000place\";s:5:\"Dakar\";s:6:\"\u0000*\u0000pub\";s:8:\"[SOPEMI]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:9:\"\u0000*\u0000jtitle\";s:25:\"M\u00e9decine d'Afrique Noire\";s:9:\"\u0000*\u0000stitle\";s:16:\"M\u00e9d. Afr. Noire\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"239\";s:8:\"\u0000*\u0000epage\";s:3:\"243\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0465-4668\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KIBADI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:13:\"TSAKALA, T. M\";i:1;s:17:\"MPUTU YAMBA, J. B\";i:2;s:12:\"KASHONGWE, M\";i:3;s:10:\"MUYEMBE, T\";i:4;s:9:\"IMPOSO, I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MAFNAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:8:\"\u0000*\u0000place\";s:5:\"Dakar\";s:6:\"\u0000*\u0000pub\";s:8:\"[SOPEMI]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:9:\"\u0000*\u0000jtitle\";s:25:\"M\u00e9decine d'Afrique Noire\";s:9:\"\u0000*\u0000stitle\";s:16:\"M\u00e9d. Afr. Noire\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"239\";s:8:\"\u0000*\u0000epage\";s:3:\"243\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0465-4668\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KIBADI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:13:\"TSAKALA, T. M\";i:1;s:17:\"MPUTU YAMBA, J. B\";i:2;s:12:\"KASHONGWE, M\";i:3;s:10:\"MUYEMBE, T\";i:4;s:9:\"IMPOSO, I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MAFNAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:8:\"\u0000*\u0000place\";s:5:\"Dakar\";s:6:\"\u0000*\u0000pub\";s:8:\"[SOPEMI]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:9:\"\u0000*\u0000jtitle\";s:25:\"M\u00e9decine d'Afrique Noire\";s:9:\"\u0000*\u0000stitle\";s:16:\"M\u00e9d. Afr. Noire\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"239\";s:8:\"\u0000*\u0000epage\";s:3:\"243\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0465-4668\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KIBADI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:13:\"TSAKALA, T. M\";i:1;s:17:\"MPUTU YAMBA, J. B\";i:2;s:12:\"KASHONGWE, M\";i:3;s:10:\"MUYEMBE, T\";i:4;s:9:\"IMPOSO, I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MAFNAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:8:\"\u0000*\u0000place\";s:5:\"Dakar\";s:6:\"\u0000*\u0000pub\";s:8:\"[SOPEMI]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:9:\"\u0000*\u0000jtitle\";s:25:\"M\u00e9decine d'Afrique Noire\";s:9:\"\u0000*\u0000stitle\";s:16:\"M\u00e9d. Afr. Noire\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"239\";s:8:\"\u0000*\u0000epage\";s:3:\"243\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0465-4668\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"KIBADI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:13:\"TSAKALA, T. M\";i:1;s:17:\"MPUTU YAMBA, J. B\";i:2;s:12:\"KASHONGWE, M\";i:3;s:10:\"MUYEMBE, T\";i:4;s:9:\"IMPOSO, I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"MAFNAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:114:\"Essai th\u00e9rapeutique de l'association Chloramine Metronidazole Nitrofurantoine dans l'ulc\u00e8re de buruli surinfecte\";s:8:\"\u0000*\u0000place\";s:5:\"Dakar\";s:6:\"\u0000*\u0000pub\";s:8:\"[SOPEMI]\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
